Expanded sterile Opportunities exist in its NJ sterile injectable manufacturing expansion, signaling capacity for partnerships or contract manufacturing of sterile injectable products and complex dosage forms.

Specialty focus Teligent targets Topical, Injectable, Complex and Ophthalmic markets, indicating potential for synergy with specialty generic launches or late-stage generic expansions where niche delivery solutions are valued.

Cost reduction Recent headcount reductions and bankruptcy-related restructuring suggest a buyer-friendly environment for asset or technology acquisitions, licensing deals, or channel Realignments with continued emphasis on core asset rationalization.

Global footprint With operations in the United States, Canada, and Estonia, there are cross-border collaboration opportunities, regulatory pathway support, and regionalized supply considerations for compliant, accelerated market entry strategies.

Quality and science A strong emphasis on impactful science and uncompromising product quality suggests sales opportunities around high-potency generics or complex formulations where rigorous quality and reliability are differentiators.